While the unconjugated tubulin inhibitor MMAE dramatically reduced cell viability of TFE3-fusion RCC cells and control cells at low nanomolar concentrations (Supplementary Figure S8D), the ADC showed significantly reduced cell viability only in TFE3-fusion RCC cells (Fig. 4C). This evidence concerns the gene TFE3 and renal cell carcinoma.